Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMP Study: VRC01 for HIV Prevention in MSM and TG Persons
NCT02716675Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2016
- Primary completion
- Dec 2020
- Modality
- Anti-infectious Disease mAbs
- Countries
- 4
01
Overview
A Phase 2 trial of VRC01 in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2016; status: completed.
02
Drugs
VRC01
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02716675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716675.